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Abstract Transcription from the TOL plasmid meta-cleavage
pathway operon, Pm, depends on the XylS protein being
activated by a benzoate effector. The XylS binding sites are
two imperfect 5P-TGCAN6GGNTA-3P direct repeats located
between positions 370/356 and 349/335 [Gonza¤lez-Pe¤rez et
al. (1999) J. Biol. Chem. 274, 2286^2290]. An intrinsic bending
of 40‡, which is not essential for transcription, is centered at
position 343. We have determined the potential overlap between
the XylS and RNA polymerase binding sites. The insertion of
2 or more bp between C and T at positions 337 and 336
abolished transcription activation by the wild-type XylS and by
XylSS229I, a mutant with increased affinity for the XylS
binding sites. In contrast, a 1-bp insertion at 337 was
permissible, although when in addition to the 1-bp insertion at
337 the mutant promoter had a point mutation at the XylS
binding site (C347CT), transcription was abolished with the
wild-type XylS protein, but not with XylSS229I. The overlap
between the proximal XylS binding site and the 335 region
recognized by RNA polymerase at positions 335 and 336
appears to be critical for transcription. < 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
The sigma subunit of RNA polymerase confers sequence
recognition speci¢city for the binding of the holoenzyme to
promoters during transcription initiation [1]. In c70 and re-
lated sigma factors in Gram-negative bacteria, this binding is
mainly achieved via sequence-speci¢c contacts with bases in
the 310 and 335 regions upstream of the transcription start
site on promoters [2^5]. In promoters whose expression de-
pends on a positive regulator, in addition to sigma^DNA
interactions during initiation, protein^protein contacts also
occur between transcriptional activators and subunits of
RNA polymerase (see [6] for a review). In fact, in a number
of positively regulated promoters, the recognition sequences
of transcriptional activator proteins are adjacent to or partly
overlap the 335 region contacted by the sigma subunit of
RNA polymerase [7]. In the V PRM promoter, the binding
site of VcI overlaps the 335 region for sigma by two nucleo-
tides, and genetic experiments have suggested an interaction
between the VcI protein and the 335 region recognized by c70
[8,9]. In other promoters, i.e. the catabolite repression protein-
dependent P1gal promoter and the PhoB-dependent PptsS
promoter, the activator binding site completely overlaps the
335 hexamer, and the activator probably replaces sigma in
the recognition of the 335 region [10].
Several research groups have shown that for certain regu-
lators of the AraC/XylS family [11], i.e. AraC, Rob and RhaS,
the binding sites for the regulator overlap the 335 region of
RNA polymerase by two to four nucleotides in their cognate
promoters [7,12]. The situation is di¡erent in other members
of this family of transcriptional regulators. For instance, the
Ada recognition site seems to be separated by 2 or 5 bp from
the RNA polymerase binding site in the ada and aidB pro-
moters, respectively [13]. On the other hand, the MarA bind-
ing site can either be upstream from the 335 region (class I
promoters), or overlap the RNA polymerase binding site
(class II promoters) [14].
The TOL plasmid pWW0 of Pseudomonas putida speci¢es a
meta-cleavage pathway for the oxidative catabolism of ben-
zoate and toluates. Genes that encode the TOL meta-cleavage
pathway are grouped in an operon under the control of a
single promoter, Pm. Expression from the Pm promoter of
the meta-cleavage pathway for alkylbenzoate degradation is
under the control of the XylS regulator (see [15] for a review).
When XylS is activated by e¡ectors such as 3-methylbenzoate
(3MB), it stimulates transcription from Pm in a process medi-
ated by RNA polymerase with c32 or c38 depending on the
growth phase [16]. The target half-sites for XylS binding at
the Pm promoter are two imperfect direct repeats (5P-
TGCAN6GGNTA-3P) located between positions 370/356
and 349/335 [17,18] (Fig. 1). Therefore, the XylS proximal
0014-5793 / 02 / $22.00 G 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 2 ) 0 2 7 3 0 - 8
Fig. 1. DNA sequence of the Pm promoter. The +1, 310 and 335
positions of the Pm promoter are indicated. Arrows show the pro-
posed XylS binding sites located between 370 and 356 and be-
tween 349 and 335.
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site might share one or more nucleotides with the 335 region
for RNA polymerase recognition. In addition, a track of six
As between positions 341 and 346 in Pm may induce intrin-
sic curvature in the Pm promoter and thereby in£uence ex-
pression. This study was designed to determine if this struc-
tural organization of the promoter is essential for XylS-
mediated transcription activation from Pm.
2. Materials and methods
2.1. Bacterial strains, culture medium and plasmids
The strains and plasmids used in this study and their relevant char-
acteristics are shown in Table 1. Escherichia coli strains were grown at
30‡C in Luria^Bertani (LB) culture medium supplemented, when re-
quired, with 100 Wg/ml ampicillin (Ap), 25 Wg/ml kanamycin (Km) and
10 Wg/ml tetracycline (Tc).
2.2. DNA techniques
DNA preparation, digestion with restriction enzymes, analysis by
agarose gel electrophoresis, isolation of DNA fragments, ligations,
transformations and sequencing reactions were done according to
standard procedures [19,20] or the manufacturers’ recommendations.
2.3. Construction of Pm mutant promoters
The Pm derivatives with di¡erent length spacers between the XylS
recognition site and the RNA polymerase binding site were con-
structed as follows: pBR-Pm101 is the result of cloning Pm101, a
Pm mutant promoter bearing a unique NcoI site centered at C-42
[21], in pBR322 as a 400-bp EcoRI^HindIII fragment (Table 1).
pBR-Pm300 was obtained by inserting a 43-bp (5P-CCATGG-
GAGCTCGCTCGAGAGATCTATGCATGTTAACCCATGG-3P)
duplex DNA fragment at the unique NcoI site of pBR-Pm101. This
DNA fragment contains ¢ve non-overlapping unique restriction en-
zymes: SacI, XhoI, BglII, NsiI, and HpaI, £anked by two NcoI sites.
Pm mutant promoters Pm301 through Pm309 were obtained after
double digestion of pBR-Pm300 using di¡erent combinations of the
¢ve restriction sites mentioned above (Table 1). The linearized plas-
mids were made blunt-ended by treatment with the Klenow fragment
of DNA polymerase, and were religated with T4 DNA ligase. In the
resulting mutant promoters the proximal XylS binding site and the
335 region were separated by a DNA sequence that ranged from 37
to 7 bp. All the mutant Pm promoters from Pm300 to Pm309 were
subcloned in pMD1405 as a 401-bp EcoRI^HindIII DNA fragment to
obtain in-frame Pm*: :PlacZ fusions, which were designated pMAR-
Pm300 to pMAR-Pm309 (Table 1).
To obtain plasmids pMAR-Pm310 to pMAR-Pm319, which con-
tain a spacer region of 5 bp or less between the proximal XylS binding
site and the 335 RNA polymerase recognition region, we used over-
lap extension polymerase chain reaction (PCR) mutagenesis. The tem-
plate for each mutagenesis was 200 ng of pMT11 (Table 1), and
ampli¢cation conditions were as described by Higushi [22]. The inter-
nal primers used for mutagenesis exhibited 1^5 extra bp between the
proximal XylS binding site and the 335 RNA polymerase recognition
region with respect to the wild-type sequence. The external oligonu-
cleotides were the so-called M13 reverse primer (5P-CAGGAAA-
CAGCTATGACCATG-3P) and a primer complementary to the K
fragment of the PlacZ gene (5P-GATGTGCTGCAAGGCGAT-
TAAGTTA-3P). After DNA ampli¢cation, the resulting DNA was
digested with EcoRI and HindIII, and the 401-bp EcoRI^HindIII
Pm mutants were inserted between the EcoRI^HindIII sites of
pMD1405 to yield plasmids pMAR310 through 319, which carry in-
frame Pm*: :PlacZ fusions (see Fig. 2). All the mutant Pm promoters
generated in this study were con¢rmed by DNA sequencing.
2.4. Construction of pBend2-Pm for cyclic permutation assays
PCR was used to obtain a 401-bp DNA fragment containing the
XylS binding sites in the Pm promoter. For the PCR reaction the
template was plasmid pJLR100 (Table 1) and the primers used were
5P-GATGTGCTGCAAGGCGATTAAGTTG-3P and 5P-CGTCTAA-
GAAACCATTATTATCATG-3P. The 401-bp ampli¢ed PCR product
was digested with XbaI and SalI and the resulting 86-bp fragment was
puri¢ed by agarose gel electrophoresis, extracted and ligated between
the XbaI and SalI sites of pBend2. This plasmid contains two identical
DNA segments with 17 restriction sites on either side of XbaI and SalI
cloning sites [23,24]. The resulting plasmid pBend2-Pm was digested
with di¡erent enzymes to yield a series of 206-bp DNA fragments,
with the position of the DNA sequence carrying the XylS binding sites
permutated (Fig. 3A). These fragments were electrophoresed through
a continuous 10% (w/v) polyacrylamide gel in TBE bu¡er. To estimate
the intrinsic bend angle (K) and to locate the center of the bend, we
used the method of Thompson and Landy [25]. Values given are the
average of six independent determinations.
2.5. RNA preparation, analysis and primer extension
RNA was extracted with the guanidinium isothiocyanate^phenol
method as described previously [26]. Hybridization of the single-
stranded 32P-labelled DNA primer (about 105 counts per minute per
assay) complementary to the mRNA transcript originated from Pm,
and primer extension with avian myeloblastosis virus reverse tran-
scriptase, were carried out as described previously [26]. The cDNA
products of the reverse transcriptase reactions were separated and
analyzed in urea polyacrylamide sequencing gels.
2.6. L-Galactosidase assays
E. coli bearing the wild-type Pm: :PlacZ or mutant Pm*: :PlacZ fu-
sions in pMD1405, plus a compatible plasmid bearing the wild-type
xylS (pERD103) or mutant alleles encoding XylSS229I (pERD32)
and XylSG44S (pERD139), were grown overnight on LB medium
Table 1
Strains and plasmids used in this study
Strains or plasmids Relevant characteristics Source or
reference
Strains
E. coli MC4100 F3, araD139, (argF-lac)U169, rpsL150, relA1, £bB5301, deoC1, ptsF25, rpsR. SmR [20]
E. coli DH5K supE44 lacU169 (T80 lacZv M15) hsdR17 (r3Km
þ
K) recA1 endA1 gyrA96 thi-1 relA1 [39]
Plasmids
pBend2 Derivative of pBR322 containing 17 restriction sites in a direct repeat surrounding XbaI^SalI sites [23]
pBend2-Pm pBend2 derivative carrying a 86-bp DNA fragment containing a 75-bp Pm promoter spanning from
A-27 to A-100 with respect to the main transcription initiation point, cloned between XbaI^SalI sites
This study
pBR322 ColE1, ApR, TcR [40]
pBR-Pm101 Mutant Pm101 bearing a NcoI site in the proximal XylS binding site, cloned in pBR322 This study
pBR-Pm300 to 309 Pm300^309 in pBR322, ApR, TcR This study
pERD32 xylS mutant allele encoding XylSS229I, IncQ, KmR [41]
pERD103 xylS, IncQ, KmR [41]
pERD139 xylS mutant allele encoding XylSG44S, IncQ, KmR [42]
pJLR100 Pm cloned in pEMBL9, ApR [43]
pJLR107 Pm: :PlacZ in pMD1405, ApR [43]
pMAR-Pm300 to 319 Pm300^319: :PlacZ in pMD1405, ApR This study
pMD1405 Promoterless PlacZ, ApR [43]
pMT11 Pm101: :PlacZ in pMD1405, ApR [21]
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containing the appropriate antibiotics. Three clones of each strain
were used. Cultures were diluted 100-fold in the same medium sup-
plemented or not with 1 mM of 3MB. After 4 h of incubation, cells
had reached the logarithmic phase. L-Galactosidase activity was de-
termined in permeabilized whole cells according to Miller [27].
3. Results
3.1. Overlap of the proximal XylS binding site and the 335
region recognized by RNA polymerase
To determine whether the proximal XylS binding site and
the RNA polymerase site overlapped in the 335 region, we
designed a series of mutant promoters based on the mutant
Pm101, in which a NcoI site had been introduced by replacing
A342 and A343 with CC. We used this site to clone a 43-mer
linker with several restriction sites. This insertion preserved
the promoter sequence up to 340 but moved the critical
TGCA from 349/346 to 386/383 and the furthest TGCA
in the wild-type from 370/367 to 3107/3104. Through a
series of internal deletions within the linker, the proximal
TGCA was brought to positions 382/379, 380/377, 378/
375, 377/374, 376/373, 374/371, 370/367, 363/360
and 358/355. The structure of the last promoter, called
Pm309, is shown in Fig. 2.
The di¡erent mutant promoters were fused to PlacZ. As a
control we used the Pm101: :PlacZ fusion. L-Galactosidase
activity was determined in a XylS-pro¢cient background in
the absence and in the presence of 3MB. In the control strain
L-galactosidase activity reached about 5000 Miller units (Fig.
2); in contrast, levels induced in the Pm mutant promoters
were never higher than 100 Miller units (Fig. 2). We therefore
concluded that transcription from the mutant Pm promoters
was not activatable by the XylS protein with 3MB.
This lack of activity may be attributable to the increased
distance between the TGCA motif and the 335 region, or to
the modi¢cation of the sequence introduced at the 3P-end of
the proximal XylS binding site at Pm. To determine the exact
cause, we tested the activation of mutant Pm promoters by
XylSS229I and XylSG44S. These two mutant regulators,
which have increased a⁄nity for Pm binding sites, suppressed
mutations in the 349/346 TGCA critical motif of Pm which
otherwise prevented activation of transcription by the wild-
type XylS regulator [17]. However, regardless of the presence
of 3MB, transcription from Pm309 was not stimulated by
either of these two mutant regulators. These results suggest
that the lack of activity in the Pm300^309 series was probably
due to the insertion of nine or more nucleotides between the
XylS binding site and the 335 region.
On the basis of these results we decided to introduce shorter
insertions between the 335 region and the XylS binding site.
We used overlapping PCR mutagenesis to introduce 5, 4, 3,
2 or 1 bp between C at position 337 and T at position 336.
The mutant promoters were designated Pm310 through
Pm313 and Pm319 (Fig. 2). Mutants Pm314 and Pm315, in
addition to the extra 1-bp insertion located at 337, carried
additional mutations and were retained for further studies (see
Fig. 2). The mutant promoters were fused to PlacZ and then
used to test induction with XylS, XylSG44S and XylSS229I in
cultures with and without 3MB. Negligible levels of transcrip-
tion from Pm310 through Pm313, as compared to the wild-
type, were found regardless of the regulator used, and regard-
less of the presence or absence of the e¡ector. These results
suggested that the insertion of 2 or more bp between 336 and
337 already prevented transcription stimulation by both wild-
type XylS and mutant XylS proteins (Fig. 2). The fact that
XylSS229I was not able to suppress the mutations at Pm
contrasts with its ability to restore inducibility in Pm pro-
moters with one or more changes in the critical 349/346
box for XylS recognition [17,21]. This implies that an inser-
tion as short as 2 bp can impair overlap site recognition by
the positive regulator and RNA polymerase, or a¡ect the
interaction between the two proteins.
In contrast with the above results, the insertion of 1 bp
between positions 336 and 337 in Pm319 resulted in a pat-
tern of transcription similar to that obtained for Pm101, i.e.
inducible transcription in the presence of 3MB with XylS and
constitutive expression in the case of XylSS229I (Fig. 2).
The results with the promoters that had a 1-bp insertion
and an additional mutation varied depending on the nature of
this mutation and on the regulator used. When in addition to
the A insertion at 337 the mutant promoter had a point
mutation at the critical XylS recognition box 349/346
(C347CT), as in Pm315, only XylSS229I with 3MB was
able to stimulate transcription from Pm (Fig. 2), although
at a much lower level than in Pm319. These results are in
agreement with previous ¢ndings by our group that showed
that XylSS229I suppresses mutations in the XylS binding sites
of Pm when an e¡ector is added to the culture medium
Fig. 2. Levels of L-galactosidase activity expressed from di¡erent mutant Pm promoters with di¡erent XylS regulators in the absence and in
the presence of 3MB. The ¢gure shows the nucleotides in the mutant Pm promoter from the 327 nucleotide. Each mutant Pm promoter was
fused to PlacZ in pMD1405. Nucleotides inserted between the original 336 and 337 positions are indicated in bold type; point mutations in
Pm314 and Pm315 are underlined. L-Galactosidase activity was determined in triplicate as described in Section 2. Data are the average of six
to nine independent determinations, with standard deviations below 15% of the given values. Arrows indicate the XylS binding sites.
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[17,21]. However, with Pm314, which in addition to the 1-bp
insertion had a point mutation so that A329 was changed to
C, the pattern of transcription was similar to that determined
for Pm314, except that the level of expression with XylSS229I
without 3MB was only 20% of that achieved in the presence
of 3MB.
We determined the transcription initiation point in Pm319,
Pm314 and Pm315 under conditions in which expression took
place. The transcription initiation point was the same as that
found when Pm and XylS were used (not shown). This sug-
gests that the L-galactosidase activity we found re£ected acti-
vation of transcription from the mutant Pm promoters by the
mutant XylS regulators, and not from any arti¢cial newly
created promoter.
3.2. Intrinsic curvature of the Pm promoter
The Pm promoter has a track of As in the 341 to 346
region in the top strand (Fig. 1). The presence of AT-rich
regions in a DNA sequence normally induces intrinsic bend-
ing in the DNA [28]. Dimethyl sulfate assays with Pm in vitro
and in vivo revealed hypermethylation of the A located at
342, which indicated that DNA was distorted at this region
[17]. Intrinsic bending is frequently found in promoters near
the RNA polymerase binding site [29,30] and has been related
to contacts between RNA polymerase and the regulator [31].
Because the A-track in Pm was located within the XylS bind-
ing site, we decided to determine the intrinsic bending of the
Pm promoter with the cyclic permutation assays method
[32,33]. We used pBend2-Pm to construct a series of DNA
fragments containing the sequence of Pm from 327 to 3101
at di¡erent positions relative to the ends of the fragments, as
described in Section 2 (Fig. 3A). Then we compared the elec-
trophoretic mobility of the di¡erent fragments at 4‡C in poly-
acrylamide gel electrophoresis (PAGE) (Fig. 3B). To calculate
the intrinsic bending angle, K, we used the equation of
Thompson and Landy [25], which gave an intrinsic curvature
angle of the Pm promoter of 40.5‡, centered in the track of As
spanning positions 341 to 346. To assess the role of this
curvature in promoter activity, we analyzed two mutant Pm
promoters, Pm5U and Pm5D. The ¢rst one had a C347CG
mutation that abolished activity [34], whereas the second,
Pm5D (A344CG), bearing a mutation in the A-track, main-
tained 70% of its wild-type activity. Analysis of the two pro-
moters showed that bending was una¡ected by the mutation
in Pm5U, whereas both Pm5D had greatly reduced the intrin-
sic curvature (data not shown). Because there was no corre-
lation between promoter activity and the presence of curva-
ture in the 341/346 region, we suggest that intrinsic bending
around position 343 in Pm is not essential for transcription
activation in view of the fact that Pm5D, which lacks this
curvature, is still active.
4. Discussion
Protein^protein interactions between RNA polymerase and
transcriptional regulators that bind adjacent to or overlapping
the 335 region are known to occur [6]. These interactions can
take place with any of the RNA polymerase subunits, and in
some cases they are favored by the intrinsic curvature of DNA
upstream from 335 [31] or curvature induced by the binding
of the regulator [35]. In this study we show that the Pm
promoter exhibits a curvature of about 40‡ centered in a con-
tinuous series of As between 341 and 346. However, this
intrinsic curvature is not a sine qua non for transcription
activation, in spite of XylS being a class II regulator.
Several other research groups have shown that the AraC,
MarA, Rob, and RhaS binding sites overlap the 335 region
by two to four nucleotides in their cognate promoters. In
contrast, the Ada recognition site seems to be separated by
2 or 5 bp from the RNA polymerase binding site in the ada
and aidB promoters, respectively [7,13,36]. When we began
this study we did not know whether the proximal XylS bind-
ing site and the 335 region of Pm recognized by the sigma
factor of RNA polymerase overlapped. The present results
support the hypothesis that a separation of 2 or more bp
between the 335 region for RNA polymerase from the XylS
binding site has a dramatic e¡ect on XylS-dependent tran-
scription from Pm: transcription from mutant Pm promoters
was abolished in the Pm313 promoter, in which 2 bp were
inserted at 336/337. This short 2-bp insertion rendered XylS
unable to stimulate transcription. Moreover, mutant regula-
tors with increased a⁄nity for the XylS half-binding sites, i.e.
XylSS229I and XylSSG44S, were not able to suppress the
mutation at Pm. These ¢ndings contrast with the ability of
these mutant regulators to restore inducibility in Pm pro-
Fig. 3. Cyclic permutation assay constructions. A: The 86-bp DNA
fragment from Pm was cloned in pBend2. The DNA segment was
cloned between the XbaI and SalI sites (boxed); this fragment is
shown as a gray box in the di¡erent construction. Arrows show the
XylS binding site in Pm. The thick line represents the polylinker of
pBend2, where the restriction sites used to generate the di¡erent
206-bp fragments with permutated locations of Pm are indicated.
B: Electrophoretic mobility of the permutated fragments in PAGE.
Electrophoresis was carried out as described in Section 2, and the
relative mobility of each fragment was plotted against the distance
of the SalI site to the 3P end of the 206-bp fragment. Restriction
sites are denoted as follows: B: BglII; C: ClaI; E: EcoRV; S: SspI;
BH: BamHI.
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moters with one or more changes in the critical 349/346 box
for XylS recognition. Fig. 4A shows the alignment of the XylS
binding sites as deduced from in vitro and in vivo foot-print-
ing [17,37] and from transcriptional assays with several Pm
mutant promoters [17,21]. The extension of these sites sug-
gests that the XylS binding site overlaps that of RNA poly-
merase, and that these nucleotides are probably located at
335 and 336 with respect to the main transcription initiation
point. However, the fact that the insertion of 1 bp at 337 had
no signi¢cant e¡ect on transcription suggests a 1-bp overlap
between XylS and RNA polymerase at position 336 is su⁄-
cient to allow full transcription from the promoter (Fig. 4B).
For example, Pm319 was activated both by XylS and by a
mutant XylS regulator to the same extent as the reference
Pm101 promoter. In addition, mutant Pm314, which had
the 1-bp insertion at 337/336 and an additional point muta-
tion outside the RNA polymerase site at 329, was activated
by XylS in the presence of 3MB, and by XylSS299I in the
presence and absence of 3MB. When the 1-bp insertion at
337 was accompanied by a point mutation at the critical
349/346 TGCA motif (Pm315), only the mutant XylS with
the highest a⁄nity for the XylS binding sites was able to
promote a signi¢cant level of transcription. It then follows
that the pattern of transcription from the mutant Pm with a
1-bp insertion at 337 and an extra mutation behaved simi-
larly to Pm mutants without the 1 extra bp at 337 and with
the point mutation as described [17].
We suggest that overlap of the proximal XylS binding site
with that of the RNA polymerase may facilitate interactions
between XylS and RNA polymerase. In this connection it has
recently been established that XylS contacts the K subunit of
RNA polymerase [38], and at present we are trying to identify
putative speci¢c contacts between the regulator and other sub-
units of RNA polymerase.
Acknowledgements: This study was supported by Grants QLRT-2001-
00435 and QLK3-CT-2000-0170 from the European Commission, and
FEDER Grant 1FD-97-0675 from the Comisio¤n Interministerial de
Ciencia y Tecnolog|¤a. We thank M.M. Fandila and C. Lorente for
secretarial assistance and Karen Shashok for language improvement.
References
[1] Burgess, R.R., Travers, A.A., Dunn, J.J. and Bautz, E.K.F.
(1969) Nature 221, 43^46.
[2] Chenchick, A., Beabealashvilli, R. and Mirzabekov, A. (1981)
FEBS Lett. 128, 46^50.
[3] Colland, F., Fujita, N., Kotlarz, D., Bown, J.A., Meares, C.F.,
Ishihama, A. and Kolb, A. (1999) EMBO J. 18, 4049^4059.
[4] Gardella, T., Moyle, H. and Susskind, M.M. (1989) J. Mol. Biol.
206, 579^590.
[5] Siegele, D.A., Hu, J.C., Walter, W.A. and Gross, C.A. (1989)
J. Mol. Biol. 206, 591^603.
[6] Ishihama, A. (2000) Annu. Rev. Microbiol. 54, 499^518.
[7] Busby, S. and Ebright, R.H. (1997) Mol. Microbiol. 23, 853^
859.
[8] Kuldell, N. and Hochschild, A. (1994) J. Bacteriol. 176, 2991^
2998.
[9] Li, M., Moyle, H. and Susskind, M.M. (1994) Science 263, 75^
77.
[10] Kumar, A., Grimes, B., Fujita, N., Makino, K., Malloch, R.A.,
Hayward, R.S. and Ishihama, A. (1994) J. Mol. Biol. 235, 405^
413.
[11] Gallegos, M.T., Schleif, R., Bairoch, A., Hofmann, K. and Ra-
mos, J.L. (1997) Microbiol. Mol. Biol. Rev. 61, 393^410.
[12] Dhiman, A. and Schleif, R. (2000) J. Bacteriol. 182, 5076^5081.
[13] Landini, P., Bown, J.A., Volkert, M.R. and Busby, S.J. (1998)
J. Biol. Chem. 273, 13307^13312.
[14] Martin, R.G., Gillette, W.K. and Rosner, J.L. (2000) Mol.
Microbiol. 35, 623^634.
[15] Ramos, J.L., Marque¤s, S. and Timmis, K.N. (1997) Annu. Rev.
Microbiol. 51, 341^373.
[16] Marque¤s, S., Manzanera, M., Gonzalez-Pe¤rez, M.M., Gallegos,
M.T. and Ramos, J.L. (1999) Mol. Microbiol. 31, 1105^1113.
[17] Gonza¤lez-Pe¤rez, M.M., Ramos, J.L., Gallegos, M.T. and Mar-
que¤s, S. (1999) J. Biol. Chem. 274, 2286^2290.
[18] Kessler, B., de Lorenzo, V. and Timmis, K. (1993) J. Mol. Biol.
230, 699^703.
[19] Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seid-
man, J.G., Smith, J.A. and Struhl, K. (1991) Current Protocols in
Molecular Biology, Wiley, New York.
[20] Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular
Cloning: a Laboratory Manual, Cold Spring Harbor Laboratory,
Cold Spring Harbor, NY.
[21] Gallegos, M.T., Marque¤s, S. and Ramos, J.L. (1996) J. Bacteriol.
178, 6427^6434.
[22] Higushi, R. (1990) Recombinant PCR, PCR Protocols. A Guide
to Methods and Applications, pp. 177^183, Academic Press, San
Diego, CA.
[23] Kim, J., Zwieb, C., Wu, C. and Adhya, S. (1989) Gene 85, 15^23.
[24] Wu, H.M. and Crothers, D.M. (1984) Nature 308, 509^513.
[25] Thompson, J.F. and Landy, A. (1988) Nucleic Acids Res. 16,
9687^9705.
[26] Manzanera, M., Aranda-Olmedo, I., Ramos, J.L. and Marque¤s,
S. (2001) Microbiology 147, 1323^1330.
[27] Miller, J. (1972) Experiments in Molecular Genetics, Cold Spring
Harbor Laboratory, Cold Spring Harbor, NY.
[28] Bolshoy, A., McNamara, P., Harrington, R.E. and Trifonov,
E.N. (1991) Proc. Natl. Acad. Sci. USA 88, 2312^2316.
[29] Lozinski, T., Adrych-Rozek, K., Markiewicz, W.T. and Wierz-
chowski, K. (1991) Nucleic Acids Res. 19, 2947^2953.
[30] Pe¤rez-Martin, J. and de Lorenzo, V. (1997) Annu. Rev. Micro-
biol. 51, 593^628.
[31] Nickerson, C.A. and Achberger, E.C. (1995) J. Bacteriol. 177,
5756^5761.
Fig. 4. Alignment of the distal and proximal XylS binding sites.
A: The distal and proximal XylS sites were aligned from the highly
conserved TGCA submotifs. W indicates critical residues deduced
from foot-printing and mutational analysis (mutations in these resi-
dues result in a decrease in transcription of more than 90%); 5 indi-
cates positions in which point mutations result in moderate loss of
activity, i.e. between 30% and 70%; * indicates residues not con-
tacted by XylS, (point mutations in these positions had no signi¢-
cant e¡ect on activity). B: Physical organization of the proximal
XylS binding site and the putative 310/335 RNA polymerase
boxes. Dashed boxes represent the proposed 310 and 335 regions
recognized by RNA polymerase. The closed box represents the
proximal XylS binding site as deduced from genetic assays and se-
quence alignments [17,18,37].
FEBS 26091 13-5-02
M.M. Gonza¤lez-Pe¤rez et al./FEBS Letters 519 (2002) 117^122 121
[32] Shpigelman, E.S., Trifonov, E.N. and Bolshoy, A. (1993) Com-
put. Appl. Biosci. 9, 435^440.
[33] Crothers, D.M. and Drak, J. (1992) Methods Enzymol. 212, 46^
71.
[34] Marque¤s, S., Gallegos, M.T. and Ramos, J.L. (1995) Mol. Mi-
crobiol. 18, 851^857.
[35] Bourgerie, S.J., Micha¤n, C.M., Thomas, M.S., Busby, S.J. and
Hyde, E.I. (1997) Nucleic Acids Res. 25, 1685^1693.
[36] Artsimovitch, I., Murakami, K., Ishihama, A. and Howe, M.M.
(1996) J. Biol. Chem. 271, 32343^32348.
[37] Kaldalu, N., Toots, U., de Lorenzo, V. and Ustav, M. (2000)
J. Bacteriol. 182, 1118^1126.
[38] Ruiz, R., Ramos, J.L. and Egan, S.M. (2001) FEBS Lett. 491,
207^211.
[39] Hanahan, D. (1983) J. Mol. Biol. 166, 557^580.
[40] Bolivar, F., Rodriguez, R.L., Betlach, M.C. and Boyer, H.W.
(1977) Gene 2, 75^93.
[41] Zhou, L.M., Timmis, K.N. and Ramos, J.L. (1990) J. Bacteriol.
172, 3707^3710.
[42] Micha¤n, C., Zhou, L., Gallegos, M.T., Timmis, K.N. and Ra-
mos, J.L. (1992) J. Biol. Chem. 267, 22897^22901.
[43] Ramos, J.L., Stolz, A., Reineke, W. and Timmis, K.N. (1986)
Proc. Natl. Acad. Sci. USA 83, 8467^8471.
FEBS 26091 13-5-02
M.M. Gonza¤lez-Pe¤rez et al./FEBS Letters 519 (2002) 117^122122
